Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
About this item
Full title
Author / Creator
Lipson, David A , Barnhart, Frank , Brealey, Noushin , Brooks, Jean , Criner, Gerard J , Day, Nicola C , Dransfield, Mark T , Halpin, David M.G , Han, MeiLan K , Jones, C. Elaine , Kilbride, Sally , Lange, Peter , Lomas, David A , Martinez, Fernando J , Singh, Dave , Tabberer, Maggie , Wise, Robert A , Pascoe, Steven J and IMPACT Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
The frequency of COPD exacerbations during treatment with a triple inhaler — delivering a long-acting beta-agonist (LABA), a long-acting muscarinic antagonist (LAMA), and an inhaled glucocorticoid — was compared with that with a LABA–LAMA or LABA–inhaled glucocorticoid.
Alternative Titles
Full title
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Authors, Artists and Contributors
Author / Creator
Barnhart, Frank
Brealey, Noushin
Brooks, Jean
Criner, Gerard J
Day, Nicola C
Dransfield, Mark T
Halpin, David M.G
Han, MeiLan K
Jones, C. Elaine
Kilbride, Sally
Lange, Peter
Lomas, David A
Martinez, Fernando J
Singh, Dave
Tabberer, Maggie
Wise, Robert A
Pascoe, Steven J
IMPACT Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_02056333v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_02056333v1
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1713901
